Inflammation Research Center, Unit of Cellular and Molecular (Patho)Physiology, Vlaams Instituut voor Biotechnologie (VIB), 9052 Ghent, Belgium; Department of Biomedical Molecular Biology, Ghent University, 9052 Ghent, Belgium.
Inflammation Research Center, Unit of Cellular and Molecular (Patho)Physiology, Vlaams Instituut voor Biotechnologie (VIB), 9052 Ghent, Belgium; Department of Biomedical Molecular Biology, Ghent University, 9052 Ghent, Belgium.
Trends Immunol. 2016 Sep;37(9):621-633. doi: 10.1016/j.it.2016.07.002. Epub 2016 Jul 30.
Optineurin (OPTN) was initially identified as a regulator of NF-κB and interferon signaling, but attracted most attention because of its association with various human disorders such as glaucoma, Paget disease of bone, and amyotrophic lateral sclerosis. Importantly, OPTN has recently been identified as an autophagy receptor important for the autophagic removal of pathogens, damaged mitochondria, and protein aggregates. This activity is most likely compromised in patients carrying OPTN mutations, and contributes to the observed phenotypes. In this review we summarize recent studies describing the molecular mechanisms by which OPTN controls immunity and autophagy, and discuss these findings in the context of several diseases that have been associated with OPTN (mal)function.
视神经萎缩症相关蛋白(OPTN)最初被鉴定为 NF-κB 和干扰素信号的调节剂,但因其与多种人类疾病(如青光眼、骨 Paget 病和肌萎缩性侧索硬化症)有关而备受关注。重要的是,OPTN 最近被确定为一种自噬受体,对于病原体、受损线粒体和蛋白质聚集体的自噬清除至关重要。这种活性很可能在携带 OPTN 突变的患者中受到损害,并导致观察到的表型。在这篇综述中,我们总结了描述 OPTN 控制免疫和自噬的分子机制的最新研究,并在与 OPTN(功能)异常相关的几种疾病的背景下讨论了这些发现。